F · Healthcare

DP8 (DP8)

Biotechnology

DP8 (DP8) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-03-28, reported market cap is $30.74M, P/E ratio is 18.00, net margin is 0.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Key metrics for DP8

Market cap
$30.74M
P/E ratio
18.00
Gross profit (TTM)
$-17.81M
Net margin
0.0%

DP8 (DP8) — FAQ

What is DP8's market cap?

DP8 (DP8) has a reported market cap of $30.74M (data as of 2026-03-28).

What is DP8's P/E ratio?

The price-to-earnings (P/E) ratio for DP8 (DP8) is 18.00 (data as of 2026-03-28).

Does DP8 pay a dividend?

Dividend yield is not available in the current snapshot for DP8 (DP8). Check the MyAverix Finance app for the latest dividend data.

What sector is DP8 in?

DP8 (DP8) is classified in the Healthcare sector (Biotechnology industry).

What exchange is DP8 listed on?

DP8 is listed on F.

What is DP8's net margin?

DP8 (DP8) reports a net margin of 0.0% (data as of 2026-03-28).

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

App Store Google Play